MYSOLINE vs OCREVUS ZUNOVO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. MYSOLINE and OCREVUS ZUNOVO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYSOLINE	OCREVUS ZUNOVO
Rating	74/100	72/100
Pharmacy pays	~$2.89 /30	—
Type	RX	RX
Active ingredient	PRIMIDONE	OCRELIZUMAB AND HYALURONIDASE-OCSQ
Manufacturer	Valeant Pharm Intl	Genentech Inc
Dosage forms	Tablet	Injectable
Drug class	Anti-Epileptic Agent	—
Boxed warning	None	None
Treats	Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor	—

mysoline ocrevus zunovo

Rating

74/100

72/100

Pharmacy pays

~$2.89 /30

—

Type

Active ingredient

PRIMIDONE

OCRELIZUMAB AND HYALURONIDASE-OCSQ

Manufacturer

Valeant Pharm Intl

Genentech Inc

Dosage forms

Tablet

Injectable

Drug class

Anti-Epileptic Agent

—

Boxed warning

None

Treats

Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

—

Frequently asked questions

Which is better-rated, Mysoline or Ocrevus Zunovo?

By our independent rating, Mysoline scores higher — 3.7 vs 3.6 out of 5 for Ocrevus Zunovo. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mysoline and Ocrevus Zunovo?

Mysoline contains Primidone, while Ocrevus Zunovo contains Ocrelizumab and Hyaluronidase-Ocsq — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.